TickerFactsScreenerDevelopers

OCULAR THERAPEUTIX, INC (OCUL) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $5.33M2012: $23.85M2013: $17.50M2014: $37.39M2015: $30.78M2016: $32.94M2017: $41.54M2018: $54.06M2019: $54.44M2020: $228.06M2021: $164.16M2022: $102.30M2023: $195.81M2024: $392.10M2025: $737.06M$737.06M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$737.06M+88.0%
2024$392.10M+100.2%
2023$195.81M+91.4%
2022$102.30M-37.7%
2021$164.16M-28.0%
2020$228.06M+318.9%
2019$54.44M+0.7%
2018$54.06M+30.2%
2017$41.54M+26.1%
2016$32.94M+7.0%
2015$30.78M-17.7%
2014$37.39M+113.6%
2013$17.50M-26.6%
2012$23.85M+347.5%
2011$5.33M—